SODIUM CITRATE   0.11M

Sodium Citrate plays a pivotal role in the anticoagulation of whole blood specimens, serving as a fundamental component in hemostasis testing across both human and non-human species. The International Committee of Thrombosis and Hemostasis, Subcommittee on Platelets, recommends a specific concentration of 0.11M for optimal results in platelet function and other hemostasis tests. This concentration ensures a harmonious balance, with the recommended ratio of whole blood to sodium citrate being 9 to 1.

Versatility is a key attribute of Sodium Citrate, making it suitable for anticoagulation not only in human subjects but also in non-human primates and various other species. This adaptability extends its application to a wide range of research and clinical scenarios, facilitating comprehensive hemostasis studies.

To enhance convenience and flexibility in laboratory procedures, Sodium Citrate is thoughtfully packaged in bulk at a concentration of 3.2%. This bulk packaging caters to the diverse needs of laboratories engaged in procedures that may require varying anticoagulant volumes. Each package contains a net volume of 237 mL, ensuring an ample supply for multiple testing sessions.

Sodium Citrate, formulated at the recommended concentration and thoughtfully bulk packaged, stands as a reliable and versatile anticoagulant, meeting the stringent requirements of hemostasis testing across different species and laboratory settings.